(Q47655625)
Statements
1 reference
PKC 412 FLT3 inhibitor therapy in AML: results of a phase II trial (English)
1 reference
Stone RM
1 reference
De Angelo J
1 reference
Galinsky I
1 reference
Estey E
1 reference
Klimek V
1 reference
Grandin W
1 reference
Lebwohl D
1 reference
Yap A
1 reference
Cohen P
1 reference
Fox E
1 reference
Neuberg D
1 reference
Clark J
1 reference
Gilliland DG
1 reference
Griffin JD
1 reference
1 January 2004
1 reference
83 Suppl 1
1 reference
S89-90
1 reference